John H. Anneken, Ph.D. - Publications
Affiliations: | Pharmaceutical Sciences/Biopharmaceuticals | University of Cincinnati, Cincinnati, OH |
Area:
Neuropharmacology of amphetaminesYear | Citation | Score | |||
---|---|---|---|---|---|
2016 | Anneken JH, Angoa-Perez M, Sati GC, Crich D, Kuhn DM. Dissecting the influence of two structural substituents on the differential neurotoxic effects of methamphetamine and mephedrone on dopamine nerve endings with the use of 4-methylmethamphetamine and methcathinone. The Journal of Pharmacology and Experimental Therapeutics. PMID 28039330 DOI: 10.1124/Jpet.116.237768 | 0.305 | |||
2013 | Anneken JH, Cunningham JI, Collins SA, Yamamoto BK, Gudelsky GA. MDMA increases glutamate release and reduces parvalbumin-positive GABAergic cells in the dorsal hippocampus of the rat: role of cyclooxygenase. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 8: 58-65. PMID 23179355 DOI: 10.1007/S11481-012-9420-X | 0.438 | |||
2012 | Anneken JH, Gudelsky GA. MDMA produces a delayed and sustained increase in the extracellular concentration of glutamate in the rat hippocampus. Neuropharmacology. 63: 1022-7. PMID 22842073 DOI: 10.1016/J.Neuropharm.2012.07.026 | 0.438 | |||
Show low-probability matches. |